Publication | Closed Access

Targeted delivery of PROTAC-based prodrug activated by bond-cleavage bioorthogonal chemistry for microneedle-assisted cancer therapy

NanomedicineMedicinal ChemistryDrug TargetingNanotherapeuticsEngineeringBond-cleavage Bioorthogonal ChemistryPolymer-drug ConjugateMedicineMicroneedle-assisted Cancer TherapyDrug Delivery SystemsNano-drug DeliveryTumor TargetingBiomedical EngineeringDrug Delivery SystemPharmacologyProtac-based ProdrugDrug Discovery